The sharp reversal from a strong Q1 (net income +42.5%) to a Q2 decline suggests margin pressure is building. Watch for cost containment efforts and any guidance adjustments in the next 10-Q. The ongoing IRA pharmacy headwind (cumulative $18.19M YTD) will continue to weigh on pharmacy segment profitability.
Price Chart
Executive Summary
Weis Markets reported Q2 2026 revenue of $1.28B (+4.6% YoY) but net income fell 9.6% to $22.86M and EPS dropped to $0.92 from $0.96, hurt by operating cost increases and a $10.71M pharmacy headwind from the Inflation Reduction Act. Comparable store sales grew 2.3%, but the margin compression signals weakening profitability despite top-line growth.
Key Financial Metrics
Key Facts
- Total revenue $1.275B for Q2 2026, up 4.6% from $1.219B a year ago
- Net income $22.86M, down 9.6% from $25.28M in Q2 2025
- EPS $0.92 vs $0.96 in the prior-year quarter, a 4.2% decline
- Comparable store sales increased 2.3% on an individual year basis; excluding fuel declined 0.4%
- Pharmacy revenue impacted by ~$10.71M due to IRA maximum fair price provisions
- Operating expenses rose $22.9M (+8.3%) outpacing gross profit growth of $21.7M (+7.1%)
Financial Impact
Net income fell 9.6% to $22.86M despite 4.6% revenue growth, driven by operating expense increases and a $10.71M pharmacy headwind.
Risk Factors
- Operating expense growth outpacing gross profit, compressing margins
- IRA maximum fair price provisions continuing to pressure pharmacy revenue (cumulative $18.19M YTD)
- Competitive pricing environment limiting ability to pass on cost increases
- Restatement-related shareholder actions and expenditures referenced in forward-looking statements
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000105418-26-000048 |
| Document: wmk-20260804x8k.htm | 0000105418-26-000048 |
| Document: 0000105418-26-000048-index-headers.html | 0000105418-26-000048 |
| Document: 0000105418-26-000048-index.html | 0000105418-26-000048 |
| Document: 0000105418-26-000048.txt | 0000105418-26-000048 |
| 8-K Data (Synthetic) | 0000105418-26-000048 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 4, 2026 11w ago | 8-K | $74.66 $70.39 | ▲ +5.72% | ▲ +5.12% | $77.65 (−4.00%) |
Aug 4, 2026 11w ago | Press Release | $74.66 $70.39 | ▼ −5.72% | ▼ −5.12% | $77.65 (+4.00%) |
Jul 16, 2026 14w ago | Press Release | $78.05 $70.93 | ▼ −9.12% | ▼ −13.57% | $77.65 (−0.51%) |
May 6, 2026 24w ago | 8-K | $71.30 $73.85 | ▲ +3.58% | ▲ +0.80% | $77.65 (+8.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers